{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:42:56Z","timestamp":1773207776179,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Urinary tract infections (UTIs) are one of the most common bacterial infections in children. In children\u2009&lt;\u20097\u00a0years of age, the prevalence of one episode of symptomatic UTI has been estimated at 3\u20137% in girls and 1\u20132% in boys, whereas 8\u201330% of them will have one or more episodes of UTI. The use of some probiotics appears to reduce the risk of recurrence of UTIs. Since the effects of probiotics are strain-specific, the efficacy and safety of each strain has to be assessed. The main aim of this study is to determine whether probiotics (containing <jats:italic>Lactobacillus rhamnosus PL1<\/jats:italic> and <jats:italic>Lactobacillus plantarum PM1)<\/jats:italic> therapy are effective in preventing UTI in children compared to placebo.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Method<\/jats:title>\n<jats:p>A superiority, double-blind, randomised, controlled trial is being conducted. One hundred and six patients aged 3 to 18\u00a0years with recurrent UTIs in last year (defined as:\u2009\u2265\u20092 episodes of UTI with acute pyelonephritis\/upper UTI; or 1 episode of UTI with acute pyelonephritis and\u2009\u2265\u20091 episodes of UTI with cystitis\/lower UTI; or\u2009\u2265\u20093 episodes of UTI with cystitis\/lower UTI) or children with\u2009\u2265\u20091 infection in the upper urinary tract and\u2009\u2265\u20091 of recurrent UTIs risk factors (congenital anomalies of the kidney and urinary tract, constipation, bladder dysfunction, myelomeningocele, sexual activity in girls) will be randomly assigned to receive a 90-day prophylaxis arm (probiotic containing <jats:italic>L. rhamnosus PL1<\/jats:italic> and <jats:italic>L. plantarum PM1<\/jats:italic>) or a 90-day placebo arm. The primary outcome measure will be the frequency of recurrence of UTI during the intervention and in the period 9\u00a0months after the intervention.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>The findings of this randomised controlled trial (RCT), whether positive or negative, will contribute to the formulation of further recommendations on prevention of recurrent UTIs in children.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title><jats:italic>Trial registration number<\/jats:italic>\n<\/jats:title>\n<jats:p>NCT03462160, date of trial registration 12th March 2018.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12894-020-00723-1","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T06:03:02Z","timestamp":1603432982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1 versus placebo as a prophylaxis for recurrence urinary tract infections in children: a study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"20","clinical-trial-number":[{"clinical-trial-number":"nct03462160","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6525-0882","authenticated-orcid":false,"given":"Maria","family":"Daniel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-5481","authenticated-orcid":false,"given":"Hanna","family":"Szymanik-Grzelak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7117-6597","authenticated-orcid":false,"given":"Agnieszka","family":"Turczyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4566-7074","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Pa\u0144czyk-Tomaszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"issue":"6 Suppl 1","key":"723_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.jped.2015.05.003","volume":"91","author":"AC Sim\u00f5es Silva","year":"2015","unstructured":"Sim\u00f5es Silva AC, Oliviera EA. Update on the approach of urinary tract infection in childhood. J Pediatr (Rio J). 2015;91(6 Suppl 1):S2\u201310. https:\/\/doi.org\/10.1016\/j.jped.2015.05.003.","journal-title":"J Pediatr (Rio J)"},{"key":"723_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/adc.66.2.232","volume":"66","author":"A Hellstr\u00f6m","year":"1991","unstructured":"Hellstr\u00f6m A, Hanson E, Hansson S, Hj\u00e4lm\u00e5s K, Jodal U. Association between urinary symptoms at 7 years old and previous urinary tract infection. Arch Dis Child. 1991;66:232\u20134.","journal-title":"Arch Dis Child"},{"issue":"2","key":"723_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.298.2.179","volume":"298","author":"PH Conway","year":"2007","unstructured":"Conway PH, Cnaan A, Zaoutis T, Brandon VH, Grundmeier RW, Keren R. Recurrent urinary tract infections in children risk factors and association with prophylactic antimicrobials. JAMA. 2007;298(2):179\u201386. https:\/\/doi.org\/10.1001\/jama.298.2.179.","journal-title":"JAMA"},{"key":"723_CR4","unstructured":"National Institute for Health and Care Excellence. Urinary tract infections in children and young people. 2013. www.nice.org.uk\/guidance\/qs36."},{"issue":"3","key":"723_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.eururo.2014.11.007","volume":"67","author":"R Stein","year":"2015","unstructured":"Stein R, Dogan HS, Hoebeke P, Ko\u010dvara R, Nijman RJ, Radmayr C, Tekg\u00fcl S, European Association of Urology, European Society for Pediatric Urology. Urinary tract infections in children: EAU\/ESPU guidelines. Eur Urol. 2015;67(3):546\u201358. https:\/\/doi.org\/10.1016\/j.eururo.2014.11.007.","journal-title":"Eur Urol"},{"issue":"4","key":"723_CR6","first-page":"159","volume":"10","author":"A \u017burowska","year":"2016","unstructured":"\u017burowska A, Wasilewska A, Jung A, Kili\u015b-Pstrusi\u0144ska K, Pa\u0144czyk-Tomaszewska M, Sikora P, Tkaczyk M, Zago\u017cd\u017con I. Zalecenia Polskiego Towarzystwa Nefrologii Dzieci\u0119cej dotycz\u0105ce post\u0119powania z dzieckiem z zaka\u017ceniem uk\u0142adu moczowego. Forum Medycyny Rodzinnej. 2016;10(4):159\u201378.","journal-title":"Forum Medycyny Rodzinnej"},{"key":"723_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1542\/peds.2011-1330","volume":"128","author":"Subcommittee on Urinary Tract Infection","year":"2016","unstructured":"Subcommittee on Urinary Tract Infection. Reaffirmation of AAP clinical practice guideline: the diagnosis and management of the initial urinary tract infection in febrile infants and young children 2\u201324 months of age. Pediatrics. 2016;128:595\u2013610.","journal-title":"Pediatrics"},{"issue":"3","key":"723_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1542\/peds.2005-1362","volume":"117","author":"EH Garin","year":"2006","unstructured":"Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics. 2006;117(3):626\u201332.","journal-title":"Pediatrics"},{"issue":"5","key":"723_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s00284-011-0006-2","volume":"63","author":"S Amdekar","year":"2011","unstructured":"Amdekar S, Singh V, Singh DD. Probiotic therapy: immunomodulating approach toward urinary tract infection. Curr Microbiol. 2011;63(5):484\u201390. https:\/\/doi.org\/10.1007\/s00284-011-0006-2(Epub 2011 Sep 7. Review).","journal-title":"Curr Microbiol"},{"issue":"4","key":"723_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s12519-016-0013-2","volume":"12","author":"SJ Lee","year":"2016","unstructured":"Lee SJ, Cha J, Lee JW. Probiotics prophylaxis in pyelonephritis infants with normal urinary tracts. World J Pediatr. 2016;12(4):425\u20139 (Epub 2016 April 8).","journal-title":"World J Pediatr"},{"issue":"4","key":"723_CR11","first-page":"430","volume":"23","author":"MJ Mohseni","year":"2013","unstructured":"Mohseni MJ, Aryan Z, Emamzadeh-Fard S, Paydary K, Mofid V, Joudaki H, Kajbafzadeh AM. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iran J Pediatr. 2013;23(4):430\u20138.","journal-title":"Iran J Pediatr"},{"issue":"2","key":"723_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5662\/wjm.v5.i2.13","volume":"5","author":"K Tewary","year":"2015","unstructured":"Tewary K, Narchi H. Recurrent urinary tract infections in children: preventive interventions other than prophylactic antibiotics. World J Methodol. 2015;5(2):13\u20139. https:\/\/doi.org\/10.5662\/wjm.v5.i2.13(eCollection 2015 Jun 26).","journal-title":"World J Methodol"},{"issue":"9","key":"723_CR13","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00467-007-0507-1","volume":"22","author":"SJ Lee","year":"2007","unstructured":"Lee SJ, Shim YH, Cho SJ, Lee JW. Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol. 2007;22(9):1315\u201320 (Epub 2007 May 26).","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"723_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00467-014-2988-z","volume":"30","author":"SJ Lee","year":"2015","unstructured":"Lee SJ, Lee JW. Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatr Nephrol. 2015;30(4):609\u201313. https:\/\/doi.org\/10.1007\/s00467-014-2988-z(Epub 2014 Oct 30).","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"723_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00345-005-0043-1","volume":"24","author":"G Reid","year":"2006","unstructured":"Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol. 2006;24(1):28\u201332 (Epub 2005 Dec 31. Review).","journal-title":"World J Urol"},{"issue":"1","key":"723_CR16","first-page":"6607","volume":"20","author":"PM Grin","year":"2013","unstructured":"Grin PM, Kowalewska PM, Alhazzan W, Fox-Robichaud AE. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol. 2013;20(1):6607\u201314.","journal-title":"Can J Urol"},{"key":"723_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mehy.2018.03.001","volume":"114","author":"QX Ng","year":"2018","unstructured":"Ng QX, Peters C, Venkatanarayanan N, Goh YY, Ho CYX, Yeo WS. Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females. Med Hypotheses. 2018;114:49\u201354.","journal-title":"Med Hypotheses"},{"key":"723_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008772.pub2","author":"EM Schwenger","year":"2015","unstructured":"Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 2015. https:\/\/doi.org\/10.1002\/14651858.CD008772.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"723_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jpurol.2017.08.018","volume":"13","author":"M Hosseini","year":"2017","unstructured":"Hosseini M, Yousefifard M, Ataei N, Oraii A, Mirzay Razaz J, Izadi A. The efficacy of probiotics in prevention of urinary tract infection in children: a systematic review and meta-analysis. J Pediatr Urol. 2017;13(6):581\u201391. https:\/\/doi.org\/10.1016\/j.jpurol.2017.08.018(Epub 2017 Oct 9).","journal-title":"J Pediatr Urol"},{"issue":"3","key":"723_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4103\/ijmm.IJMM_16_292","volume":"35","author":"V Gupta","year":"2017","unstructured":"Gupta V, Nag D, Garg P. Recurrent urinary tract infections in women: How promising is the use of probiotics? Indian J Med Microbiol. 2017;35(3):347\u201354. https:\/\/doi.org\/10.4103\/ijmm.IJMM_16_292.","journal-title":"Indian J Med Microbiol"},{"key":"723_CR21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3945\/an.114.007229","volume":"5","author":"JM Rodr\u00edguez","year":"2014","unstructured":"Rodr\u00edguez JM. The origin of human milk bacteria: is there a bacterial entero-mammary pathway during late pregnancy and lactation? Adv Nutr. 2014;5:779\u201384.","journal-title":"Adv Nutr"},{"issue":"12","key":"723_CR22","doi-asserted-by":"publisher","first-page":"e0144831","DOI":"10.1371\/journal.pone.0144831","volume":"10","author":"DS Bouchard","year":"2015","unstructured":"Bouchard DS, Seridan B, Saraoui T, Rault L, Germon P, Gonzalez-Moreno C, Nader-Macias FME, Baud D, Fran\u00e7ois P, Chuat V, Chain F, Langella P, Nicoli J, Loir YL, Even S. Lactic acid bacteria isolated from bovine mammary microbiota: potential allies against bovine mastitis. PLoS ONE. 2015;10(12):e0144831. https:\/\/doi.org\/10.1371\/journal.pone.0144831.","journal-title":"PLoS ONE"},{"key":"723_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/jclinpath-2015-202976","volume":"69","author":"A Cerbo","year":"2016","unstructured":"Cerbo A, Palmieri B, Aponte M, Morales-Medina JC, Iannitti T. Mechanisms and therapeutic effectiveness of lactobacilli. J Clin Pathol. 2016;69:187\u2013203. https:\/\/doi.org\/10.1136\/jclinpath-2015-202976.","journal-title":"J Clin Pathol"},{"issue":"1","key":"723_CR24","doi-asserted-by":"publisher","first-page":"e18952","DOI":"10.5812\/jjm.18952","volume":"9","author":"A Manzoor","year":"2016","unstructured":"Manzoor A, Ul-Haq I, Baig S, Qazi JI, Seratlic S. Efficacy of locally isolated lactic acid bacteria against antibiotic-resistant uropathogens. Jundishapur J Microbiol. 2016;9(1):e18952.","journal-title":"Jundishapur J Microbiol"},{"key":"723_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.BAD-0011-2016","author":"E Salvetti","year":"2017","unstructured":"Salvetti E, O\u2019Toole PW. The genomic basis of lactobacilli as health-promoting organisms. Microbiol Spectr. 2017. https:\/\/doi.org\/10.1128\/microbiolspec.BAD-0011-2016.","journal-title":"Microbiol Spectr"},{"key":"723_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.anaerobe.2013.07.003","volume":"23","author":"RB Salah","year":"2013","unstructured":"Salah RB, Trabelsi I, Hamden K, Chouayekh H, Bejar S. Lactobacillus plantarum TN8 exhibits protective effects on lipid, hepatic and renal profiles in obese rat. Anaerobe. 2013;23:55\u201361.","journal-title":"Anaerobe"},{"key":"723_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piz025","author":"S Sadeghi-bojd","year":"2019","unstructured":"Sadeghi-bojd S, Naghshizadian R, Mazaheri M, Ghane Sharbaf F, Assadi F. Efficacy of probiotic prophylaxis after the first febrile urinary tract infection in children with normal urinary tracts. J Pediatric Infect Dis Soc. 2019. https:\/\/doi.org\/10.1093\/jpids\/piz025.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"723_CR28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/archinternmed.2012.777","volume":"172","author":"MA Beerepoot","year":"2012","unstructured":"Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, et al. Lactobacilli versus antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012;172:704\u201312.","journal-title":"Arch Intern Med"},{"key":"723_CR29","unstructured":"Urinary tract infection (recurrent): antimicrobial prescribing NICE guideline. 2018. www.nice.org.uk\/guidance\/ng112."}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00723-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-020-00723-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00723-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T19:24:07Z","timestamp":1634930647000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-020-00723-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["723"],"URL":"https:\/\/doi.org\/10.1186\/s12894-020-00723-1","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]},"assertion":[{"value":"22 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Bioethics Committee of Medical University of Warsaw approved the study protocol, the comittee\u2019 reference number is KB\/6\/2018.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Miralex company had no input into the design of the trial. The authors have no competing financial or no-financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}